Human Vaccines & Immunotherapeutics

Human Vaccines & Immunotherapeutics is an open access peer-reviewerd journal publishing international research into vaccinology and immunotherapy, including novel and experimental vaccine exploration. The journal's audience includes clinicians, researchers, medicial professionals, epidemiologists, public health workers, biotech and pharmaceutical companies and drug regulators interested in vaccinology and immunotherapy.

Human Vaccines & Immunotherapeutics is affiliated with the International Society for Vaccines (ISV).

The aim of Human Vaccines & Immunotherapeutics is to provide a platform to present and discuss developments in vaccinology and immunotherapy. The journal covers the following topics:

Research and development of novel vaccines and immunotherapeutics
Experimental vaccines and novel approaches in vaccination and immunotherapy
Vaccines and immunotherapeutics for treating non-infectious diseases, e.g., cancer
Preclinical studies and clinical trials
Licensed products and their use in the field
Impact of licensed vaccines and Immunotherapeutics on disease
Safety and perceptions of licensed vaccines
Prevention and treatment in the developing world
Epidemiology and pharmaco-economics

Although the main focus of the journal is to publish research and clinical results in humans; preclinical, animal and in vitro studies may be published where they will shed light on disease processes and therapies.

Human Vaccines & Immunotherapeutics accepts Research Articles, Reviews Articles, Mini-Reviews, Methods, Product Reviews, Case Reports, Brief Reports, Article Commentaries, Meeting Reports and Editorials for publication. The journal operates a single-anonymized peer review policy.